Benchmark Capital Advisors’s Axogen AXGN Stock Holding History

Benchmark Capital Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,500	Closed	-$193K	–	141
2017 Q2	$193K	Hold	11,500	–	–	0.15%	118
2017 Q1	$120K	Hold	11,500	–	–	0.09%	112
2016 Q4	$103K	Hold	11,500	–	–	0.09%	117
2016 Q3	$104K	Sell	11,500 -500	-4%	-$4.07K	0.08%	122
2016 Q2	$83K	Hold	12,000	–	–	0.07%	122
2016 Q1	$64K	Sell	12,000 -10,000	-45%	-$50.8K	0.06%	117
2015 Q4	$110K	Buy	22,000 +10,000	+83%	+$49.4K	0.09%	112
2015 Q3	$49K	Hold	12,000	–	–	0.04%	123
2015 Q2	$38K	Buy	+12,000	New	+$38.8K	0.03%	126

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Benchmark Capital Advisors's AXGN Position: Q3 2017 in Review

Benchmark Capital Advisors sold out of Axogen (AXGN) in Q3 2017, closing a stake of 11,500 shares — an estimated $193K sold.

Benchmark Capital Advisors first reported a position in AXGN in Q2 2015 and held it in 9 quarters. The position peaked at $193K in Q2 2017. 104 funds tracked by Wall St. Rank hold AXGN as of Q3 2017.

Benchmark Capital Advisors reported no remaining Axogen position as of Q3 2017 after selling out during the quarter.
Benchmark Capital Advisors sold 11,500 Axogen shares in Q3 2017, an estimated $193K.
Benchmark Capital Advisors first reported a position in Axogen in Q2 2015 and held it in 9 quarters.
Benchmark Capital Advisors's Axogen position peaked at $193K in Q2 2017.
104 funds tracked by Wall St. Rank held Axogen as of Q3 2017.

Based on Benchmark Capital Advisors's 13F filing for Q3 2017, filed 25 Oct 2017.